Advisors Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Advisors Asset Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,819	Closed	-$1.41M	–	1621
2019 Q3	$1.41M	Sell	20,819 -763	-4%	-$52.4K	0.03%	641
2019 Q2	$1.25M	Buy	21,582 +1,863	+9%	+$110K	0.02%	705
2019 Q1	$1.38M	Buy	19,719 +7,542	+62%	+$559K	0.02%	700
2018 Q4	$784K	Buy	12,177 +7,196	+144%	+$504K	0.02%	848
2018 Q3	$350K	Buy	+4,981	New	+$291K	0.01%	1133

Advisors Asset Management's GHDX Position: Q4 2019 in Review

Advisors Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 20,819 shares — an estimated $1.41M sold.

Advisors Asset Management first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $1.41M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Advisors Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Advisors Asset Management sold 20,819 Genomic Health, Inc. shares in Q4 2019, an estimated $1.41M.
Advisors Asset Management first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Advisors Asset Management's Genomic Health, Inc. position peaked at $1.41M in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Advisors Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.